Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

The iatrogenic pathology of percutaneous interventions in coronary arteries.

Li X, De Winter RJ, Van Der Wal AC.

Minerva Med. 2012 Dec;103(6):487-502. Review.

PMID:
23229368
2.

Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.

Doostzadeh J, Clark LN, Bezenek S, Pierson W, Sood PR, Sudhir K.

Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550. Review.

PMID:
19952925
3.

Stent thrombosis in the era of drug eluting stents.

Kawaguchi R, Angiolillo DJ, Futamatsu H, Suzuki N, Bass TA, Costa MA.

Minerva Cardioangiol. 2007 Apr;55(2):199-211. Review.

PMID:
17342038
4.
5.

[Optimal platelet inhibition after coronary stent implantation. Current status].

Silber S, Hoffmeister HM, Bode C.

Herz. 2008 Jun;33(4):244-53. doi: 10.1007/s00059-008-3138-9. Review. German.

PMID:
18581073
6.

Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.

Waksman R, Pakala R.

EuroIntervention. 2009 Dec 15;5 Suppl F:F36-42. doi: 10.4244/EIJV5IFA6. Review.

PMID:
22100674
7.

Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).

Morrison DA, Berman M, El-Amin O, McLaughlin RT, Bates ER.

Minerva Cardioangiol. 2007 Oct;55(5):593-623. Review.

PMID:
17912165
8.

Atheroma and coronary bifurcations: before and after stenting.

Yazdani SK, Nakano M, Otsuka F, Kolodgie FD, Virmani R.

EuroIntervention. 2010 Dec;6 Suppl J:J24-30. doi: 10.4244/EIJV6SUPJA5. Review.

PMID:
21930487
9.

Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications.

Lüscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R.

Circulation. 2007 Feb 27;115(8):1051-8. Review.

10.

Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.

Newsome LT, Kutcher MA, Royster RL.

Anesth Analg. 2008 Aug;107(2):552-69. doi: 10.1213/ane.0b013e3181732049. Review.

PMID:
18633035
11.
12.

Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents?

Valgimigli M, Airoldi F, Zimarino M.

J Cardiovasc Med (Hagerstown). 2009 Oct;10 Suppl 1:S17-26. doi: 10.2459/01.JCM.0000362040.25767.f5. Review.

PMID:
19851216
13.

[Stents in interventional cardiology].

Grinius V, Navickas R, Unikas R.

Medicina (Kaunas). 2007;43(3):183-9. Review. Lithuanian.

14.

Vascular responses to drug eluting stents: importance of delayed healing.

Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R.

Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1500-10. Epub 2007 May 17. Review.

15.

Emerging drugs for coronary restenosis: the role of systemic oral agents the in stent era.

Rodriguez AE.

Expert Opin Emerg Drugs. 2009 Dec;14(4):561-76. doi: 10.1517/14728210903203808. Review.

PMID:
19712016
16.

[Assessment of coronary artery stents in computed tomography: state of the art].

Krupiński M, Miszalski-Jamka T, Klimeczek P, Banyś RP, Irzyk M, Laskowicz B, Pasowicz M.

Przegl Lek. 2010;67(2):123-6. Review. Polish.

PMID:
20557013
17.

Bioabsorbable coronary stents--are these the next big thing in coronary angioplasty?

Balla S, Aggarwal K, Nistala R.

Recent Pat Cardiovasc Drug Discov. 2010 Jun;5(2):86-90. Review.

PMID:
20158469
18.

Drug-eluting stent thrombosis: an oversensationalized but unresolved problem?

Latib A, Chieffo A, Colombo A.

Monaldi Arch Chest Dis. 2007 Mar;68(1):1-5. Review. No abstract available.

PMID:
17564287
19.

Do statins have a role in reduction/prevention of post-PCI restenosis?

Prasad K.

Cardiovasc Ther. 2013 Feb;31(1):12-26. doi: 10.1111/j.1755-5922.2011.00302.x. Epub 2011 Oct 3. Review.

PMID:
21967674
20.

Pathophysiology of coronary thrombus formation and adverse consequences of thrombus during PCI.

Srikanth S, Ambrose JA.

Curr Cardiol Rev. 2012 Aug;8(3):168-76. Review.

Supplemental Content

Support Center